196 results
Page 4 of 10
8-K
EX-99.1
r5oobcoy 94i844y
29 Dec 20
Other Events
4:24pm
8-K
EX-99.1
4j6rm
22 Dec 20
Hepion Pharmaceuticals Announces FDA Clearance of IND Application for CRV431 for COVID-19
8:34am
8-K
EX-99.1
ql985vocndnzevwez
10 Dec 20
Hepion Pharmaceuticals Completes 75 mg CRV431 Dosing, Initiates 225 mg Dosing in Phase 2a 'AMBITION' Clinical Trial for NASH
11:32am
8-K
EX-99.1
xucxk wohdxi8kagcf3u
2 Dec 20
Other Events
8:12am
8-K
EX-1.1
ihtaoj
27 Nov 20
Hepion Pharmaceuticals Prices Public Offering
1:48pm
8-K
EX-99.1
r6y5fo8erb 7qnre
27 Nov 20
Hepion Pharmaceuticals Prices Public Offering
1:48pm
424B4
w3od737hgzjtstv4swqr
25 Nov 20
Prospectus supplement with pricing info
4:28pm
8-K
EX-99.1
5judrd9o4u4xonv
18 Nov 20
Hepion Pharmaceuticals Data Safety Monitoring Board Recommends Continuation of Phase 2a 'AMBITION' Clinical Trial for Treatment of Advanced NASH
8:29am
8-K
EX-99.1
jz1 ws7tc1
12 Nov 20
Hepion Pharmaceuticals to Present at The Liver Meeting Digital ExperienceTM 2020
9:33am
8-K
EX-99.1
9pvrj8y 9v7b7diw
10 Nov 20
Hepion Pharmaceuticals Completes First Cohort Enrollment in Phase 2a 'AMBITION' Clinical Trial
10:33am
8-K
EX-99.1
2t0wnatlrij0u0djvqcx
27 Oct 20
Other Events
9:45am
8-K
EX-99.1
s8634ezo4n7tah7h2
5 Oct 20
Announces Creation of Clinical Pharmacology Analytics Team
9:06am
8-K
EX-99.1
ufvdsizbs3c
17 Sep 20
Other Events
12:40pm